Abstract

The biological clock controls at the molecular level several aspects of mammalian physiology, by regulating daily oscillations of crucial biological processes such as nutrient metabolism in the liver. Disruption of the circadian clock circuitry has recently been identified as an independent risk factor for cancer and classified as a potential group 2A carcinogen to humans. Hepatocellular carcinoma (HCC) is the prevailing histological type of primary liver cancer, one of the most important causes of cancer-related death worldwide. HCC onset and progression is related to B and C viral hepatitis, alcoholic and especially non-alcoholic fatty liver disease (NAFLD)-related milieu of fibrosis, cirrhosis, and chronic inflammation. In this review, we recapitulate the state-of-the-art knowledge on the interplay between the biological clock and the oncogenic pathways and mechanisms involved in hepatocarcinogenesis. Finally, we propose how a deeper understanding of circadian clock circuitry–cancer pathways’ crosstalk is promising for developing new strategies for HCC prevention and management.

Highlights

  • Worldwide, liver cancer ranks second among the principal causes of cancer-related death and fifth in men and ninth in women among the most commonly diagnosed cancers, respectively, with more than 800,000 new cases in 2018 and hepatocellular cancer (HCC) accounting for 70–85% of all liver cancers [1,2]

  • Since macroH2A1 is mechanistically involved in the differentiation of stem cells [66,67], we recently studied its implications as an epigenetic player orchestrating liver cancer stem cell (CSC) insurgence and stemness

  • Overexpression, and consequent chromatin incorporation, of macroH2A1 proteins in hepatocytes or in Hepatocellular carcinoma (HCC) cells treated with free fatty acids lead to significant dysregulation in the expression of several clock-controlled genes involved in lipid metabolism (Figure 1) [74,75]

Read more

Summary

A Role for the Biological Clock in Liver Cancer

Gianluigi Mazzoccoli 1, * , Luca Miele 2 , Giuseppe Marrone 2 , Tommaso Mazza 3 , Manlio Vinciguerra 4, * and Antonio Grieco 2. International Clinical Research Center (FNUSA-ICRC), St. Anne’s University Hospital, 65691 Brno, Czech Republic. Received: 9 October 2019; Accepted: 6 November 2019; Published: 11 November 2019

Introduction
Hedgehog Signaling Pathway
MAP Kinase Signaling Pathways
Epigenetics
The Biological
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call